- Home
- BARK vs ABEO Comparison
BARK vs ABEO Comparison
Compare BARK & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- ABEO
- Stock Information
- Founded
- BARK 2011
- ABEO N/A
- Country
- BARK United States
- ABEO United States
- Employees
- BARK N/A
- ABEO N/A
- Industry
- BARK Department/Specialty Retail Stores
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- BARK Consumer Discretionary
- ABEO Health Care
- Exchange
- BARK Nasdaq
- ABEO Nasdaq
- Market Cap
- BARK 308.9M
- ABEO 277.6M
- IPO Year
- BARK N/A
- ABEO 1980
- Fundamental
- Price
- BARK $1.68
- ABEO $5.79
- Analyst Decision
- BARK Strong Buy
- ABEO Strong Buy
- Analyst Count
- BARK 1
- ABEO 3
- Target Price
- BARK $1.90
- ABEO $18.00
- AVG Volume (30 Days)
- BARK 804.6K
- ABEO 332.6K
- Earning Date
- BARK 11-07-2024
- ABEO 11-14-2024
- Dividend Yield
- BARK N/A
- ABEO N/A
- EPS Growth
- BARK N/A
- ABEO N/A
- EPS
- BARK N/A
- ABEO N/A
- Revenue
- BARK $488,881,000.00
- ABEO N/A
- Revenue This Year
- BARK $3.36
- ABEO N/A
- Revenue Next Year
- BARK $9.73
- ABEO $7,097.06
- P/E Ratio
- BARK N/A
- ABEO N/A
- Revenue Growth
- BARK N/A
- ABEO 147.52
- 52 Week Low
- BARK $0.70
- ABEO $3.05
- 52 Week High
- BARK $1.91
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- BARK 62.18
- ABEO 37.97
- Support Level
- BARK $1.46
- ABEO $5.63
- Resistance Level
- BARK $1.68
- ABEO $6.01
- Average True Range (ATR)
- BARK 0.10
- ABEO 0.31
- MACD
- BARK 0.03
- ABEO -0.07
- Stochastic Oscillator
- BARK 94.71
- ABEO 14.66
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.